Effectivity of interventions to prevent mental illness at the workplace

Effectivity of interventions to prevent mental illness at the workplace - WIPPE

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00011371

Enrollment

150

Registered

2016-12-16

Start date

2016-10-18

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychosomatic illness at the workplace F32

Interventions

Group 1: Group 1: Participants of a manager training for the prevention of psychological illness at the workplace. Collection of knowledge- and attitude criteria concerning mental health together with

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Group 1: Participation in a manager training concerning mental health in the survey period Group 2: Attendance at the psychosomatic consultation-hour in the survey period Group 3: Involvement in the implementation process of the inter-ventions Group 4: employees of the company

Exclusion criteria

Exclusion criteria: participants of firms not included in the agreement

Design outcomes

Primary

Measure	Time frame
Data will be collected at three different measurement dates T1 (di-rectly before/after the intervention), T2 (3 months follow-up) und T3 (12 months follow-up). Group 1 (T1 & T3): Changes in the participant’s knowledge and atti-tudes concerning mental illness via questionnaire (MAKS, Soziale Distanzskala, Einzelitems) and personal experiences with the imple-mentation process (qualitative interview) Gruppe 2 (T1, T2 & T3): Identification of changes since the consulta-tion hour (concerning the illness’ severity, life quality and work abil-ity) - via questionnaire (WAI, PHQ, SF-12, MABI, IS) and personal experiences with the implementation process (qualitative inter-view). Group 3 (T3): personal experiences with the implementation process (qualitative interview)	—

Measure

Time frame

Data will be collected at three different measurement dates T1 (di-rectly before/after the intervention), T2 (3 months follow-up) und T3 (12 months follow-up). Group 1 (T1 & T3): Changes in the participant’s knowledge and atti-tudes concerning mental illness via questionnaire (MAKS, Soziale Distanzskala, Einzelitems) and personal experiences with the imple-mentation process (qualitative interview) Gruppe 2 (T1, T2 & T3): Identification of changes since the consulta-tion hour (concerning the illness’ severity, life quality and work abil-ity) - via questionnaire (WAI, PHQ, SF-12, MABI, IS) and personal experiences with the implementation process (qualitative inter-view). Group 3 (T3): personal experiences with the implementation process (qualitative interview)

—

Secondary

Measure	Time frame
Additionally collected data: Group 1 (T1 & T3): Changes of the participant‘s job situation, work-load and the health situation. Via questionnaires (ERI, SF-12, PHQ-9, IS). Group 2 (T1, T2 & T3): patient satisfaction and changes in the partici-pant’s attitudes concerning mental illness. Via questionnaires (ZUF-8).	—

Countries

Germany

Contacts

Public ContactElena Schwarz

Kompetenzzentrum für Psychische Gesundheit am Arbeitsplatz der Universitätsklinik Ulm (LPCU)

elena.schwarz@uni-ulm.de+49 (0)731 37991 503

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026